- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/34 - Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
Patent holdings for IPC class A61K 38/34
Total number of patents in this class: 149
10-year publication summary
|
19
|
15
|
14
|
7
|
9
|
8
|
5
|
4
|
5
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Clinuvel Pharmaceuticals Limited | 23 |
12 |
| Mondobiotech Laboratories AG | 311 |
11 |
| Tyme, Inc. | 46 |
10 |
| Novo Nordisk A/S | 2273 |
9 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2072 |
7 |
| Transdermal Biotechnology, Inc. | 76 |
6 |
| Clinuvel AG | 5 |
5 |
| Genzyme Corporation | 1216 |
5 |
| Cosette Pharmaceuticals, Inc. | 51 |
5 |
| Board of Regents, The University of Texas System | 5641 |
3 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 900 |
3 |
| Intezyne Technologies, Inc. | 57 |
3 |
| Nanyang Technological University | 1903 |
3 |
| National Skin Center (S) Pte Ltd | 3 |
3 |
| Aimsco Limited | 14 |
2 |
| Emory University | 1592 |
2 |
| Fresenius Medical Care Deutschland GmbH | 2133 |
2 |
| Helix Biomedix Inc. | 33 |
2 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2637 |
2 |
| Lanzhou University | 63 |
2 |
| Other owners | 52 |